医学部

柘植 郁哉

tsuge ikuya

基本情報

所属
藤田保健衛生大学 医学部 医学科 小児科学 教授
学位
医学博士

J-GLOBAL ID
200901005526399935
researchmap会員ID
1000251707

MISC

 15
  • Takayasu Nomura, Ikuya Tsuge, Chisato Inuo, Yoichi Nakajima, Yasuto Kondo, Shiro Sugiura, Hiroaki Murata, Toshifumi Iguchi, Akihiko Terada, Shinji Saitoh, Shuji Hashimoto, Atsuo Urisu
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY 110(5) 388-390 2013年5月  
  • Takayasu Nomura, Ikuya Tsuge, Chisato Inuo, Yoichi Nakajima, Kenichi Tanaka, Norihiko Naruse, Satoko Suzuki, Hitoshi Ando, Yasuto Kondo, Shinji Saitoh, Atsuo Urisu
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY 110(5) 380-+ 2013年5月  
    Background: The involvement of a shift from T(H)2 to T(H)1 responses in peripheral blood in pollen subcutaneous immunotherapy (SCIT) has been contentious, partly because of difficulties analyzing antigen-specific T-H cells. Objectives: To use recent technical advances to establish a more direct and simple method to analyze antigen-specific T-H cells and to clarify the involvement of a T(H)2/T(H)1 shift in peripheral blood in pollen specific immunotherapy. Methods: After short-term (6-hour) antigen stimulation, antigen-specific TH cells in peripheral blood of Japanese children and young adults with Japanese cedar pollinosis undergoing SCIT were analyzed by multicolor flow cytometry for the presence of the activation marker CD154 and intracellular cytokines. Results: Twenty-eight patients between 5 and 22 years of age were enrolled in the study; 22 had started SCIT after enrolling in the study (SCIT group), and the remaining 6 were planning to start SCIT in the next off-season (control group). The number of Japanese cedar-specific interleukin (IL) 5-, IL-4-, interferon gamma-, IL-17A-, IL-10-, and tumor necrosis factor alpha-producing T-H cells without antigen-driven cell proliferation was determined. The seasonal increase in the number of Japanese cedar-specific IL-5- and IL-4-producing T-H cells seen in the control group was suppressed in the SCIT group (P < .005 and <. 001, respectively). Conclusion: We report a powerful method for the analysis of antigen-specific T-H cells in peripheral blood. This method will contribute to our understanding of immune mechanisms of immunotherapy and help us develop more sophisticated allergen specific immunotherapy. (c) 2013 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
  • Chisato Inuo, Yasuto Kondo, Yasuharu Itagaki, Kazuyuki Kurihara, Ikuya Tsuge, Tetsushi Yoshikawa, Atsuo Urisu
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY 110(4) 305-306 2013年4月  
  • 柘植 郁哉, 宇理須 厚雄
    アレルギーの臨床 33(2) 127-132 2013年  
  • Keisuke Otsubo, Hirokazu Kanegane, Yoshiro Kamachi, Ichiro Kobayashi, Ikuya Tsuge, Masue Imaizumi, Yoji Sasahara, Akira Hayakawa, Kandai Nozu, Kazumoto Iijima, Shuichi Ito, Reiko Horikawa, Yoshinori Nagai, Kiyoshi Takatsu, Hisashi Mori, Hans D. Ochs, Toshio Miyawaki
    CLINICAL IMMUNOLOGY 141(1) 111-120 2011年10月  
    Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome is an autoimmune disorder caused by mutations in the FOXP3 gene, which plays a key role in the generation of CD4(+)CD25(+)regulatory T (Treg) cells. We selected CD127 as the surface marker of Treg cells to illustrate the development and function of Treg cells in IPEX syndrome. CD4(+)CD25(+)FOXP3(+) T cells, the putative Treg cells, were almost completely absent in all patients. Importantly, a substantial number of CD4(+)CD25(+)CD127(low) T cells were observed in 3 IPEX patients with hypomorphic mutations in the FOXP3 gene. We demonstrated that CD4(+)CD25(+)CD127(low) T cells isolated from these 3 patients exhibited an appreciable suppressive activity on effector T cell proliferation, although less than that displayed by Treg cells from healthy controls. These results suggest that genetically altered FOXP3 can drive the generation of functionally immature Treg cells, but that intact FOXP3 is necessary for the complete function of Treg cells. (C) 2011 Elsevier Inc. All rights reserved.

書籍等出版物

 3

講演・口頭発表等

 4